Drreddys Laboratories | Umsatzkosten



Cost Of Sales Veränderung Datum
ANI Pharmaceuticals USD 97.9M 24.86M 2025-06
Aurora Cannabis CAD 78.85M 891K 2024-12
Bayer EUR 4.36B 1.26B 2025-06
Canopy Growth CAD 50.66M 9.51M 2024-12
Cipla INR 24.23B 2.34B 2025-06
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Drreddys Laboratories INR 34.53B 2.14B 2024-12
GlaxoSmithKline GBP 2.16B 241M 2025-06
Hikma Pharmaceutical USD 895M 82M 2024-12
Lonza CHF 2.47B 532M 2024-12
Novartis USD 3.32B 95M 2025-06
Pacira USD 55.19M 20.88M 2025-06
Prestige Brands USD 114.38M 12.13M 2025-06
Richter Gedeon HUF 69.06B 5.08B 2024-09
Sun Pharmaceuticals INR 28.15B 1.78B 2025-06
Supernus Pharmaceuticals USD 37.65M 21.88M 2025-06
Teva Pharmaceutical Industries USD 2.07B 97M 2025-06


Drreddys Laboratories Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.